Bionic aggregation-induced emission photosensitizer for enhanced cancer immunotherapy
Materials Today Bio · 2024-10 · 28 · 101217
DOI: 10.1016/j.mtbio.2024.101217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2024-10. Verfasst von Zhongxian Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medic…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Southern Medical University Nanfang Hospital.
Abstract (Originalsprache)
Cold exposure therapy (CE), as an inexpensive method, has shown great potential in cancer therapy. Exploring the combined anti-tumor mechanism of CE and traditional therapies (such as photodynamic therapy (PDT)) is exciting and promising. Here, a bionic aggregation-induced emission photosensitizer system (named THL) is designed for combined CE to enhance anti-tumor immunotherapy. THL inherits the homologous targeting ability of tumor derived exosomes, promoting the enrichment of THL at the tumor site. Under external illumination, THL generates hydroxyl radicals and superoxide anions through type I PDT. In addition, mice are pretreated with cold exposure, which promotes THL mediated PDT and reactive oxygen species (ROS) generation by reducing the production of ATP and GSH in tumor tissue. This combination therapy increases production of ROS within the tumor, inhibits the growth of distant tumors, recurrent and rechallenged tumors and increases the number of cytotoxic CD8+T cells and memory T cells. Compared to PDT alone, combination therapy shows greater advantages in tumor immunotherapy. The combination therapy strategy provides new ideas for cancer immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
- Department of Plastic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
- Department of Orthopaedic Surgery, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
- Department of Breast Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.
- The Second Ward of Breast Surgery, Cancer Hospital Affiliated to Harbin Medical University, Harbin, 150000, China.
Förderung
- Southern Medical University Nanfang Hospital
Zitieren
APA
Chen, Z., Liu, Z., Zhou, Y., Rao, K., Lin, J., Zhu, D., Ning, S., & Wang, H. (2024). Bionic aggregation-induced emission photosensitizer for enhanced cancer immunotherapy. Materials Today Bio, 28, 101217. https://doi.org/10.1016/j.mtbio.2024.101217
Vancouver
Chen Z, Liu Z, Zhou Y, Rao K, Lin J, Zhu D, et al. Bionic aggregation-induced emission photosensitizer for enhanced cancer immunotherapy. Materials Today Bio. 2024;28:101217. doi:10.1016/j.mtbio.2024.101217
BibTeX
@article{Chen2024,
author = {Chen, Zhongxian and Liu, Zeming and Zhou, Yingguang and Rao, Kexiang and Lin, Jiaxin and Zhu, Daoming and Ning, Shipeng and Wang, Hongbin},
title = {Bionic aggregation-induced emission photosensitizer for enhanced cancer immunotherapy},
journal = {Materials Today Bio},
year = {2024},
volume = {28},
pages = {101217},
doi = {10.1016/j.mtbio.2024.101217}
}
EUVIMED